The Impact of Mitochondrial Dysfunction on the Pathogenesis of Atherosclerosis
 
More details
Hide details
1
Department of Healthcare Management, Pharmacotherapy, and Clinical Pharmacy, Lviv National Medical University, Ukraine
 
2
Department of Healthcare Management, Pharmacotherapy, and Clinical Pharmacy, Faculty of Pharmacy, Danylo Halytsky Lviv National Medical University, Ukraine
 
3
Department of Propedeutics of Internal Medicine, Vinnytsia National Pyrohov Memorial Medical University, Ukraine
 
4
Department of Drug Technology, Danylo Halytsky Lviv National Medical University, Ukraine
 
5
Department of Pharmacology, Danylo Halytsky Lviv National Medical University, Ukraine
 
 
Submission date: 2023-09-14
 
 
Acceptance date: 2023-12-01
 
 
Publication date: 2024-02-23
 
 
Corresponding author
Nataliia Stepaniuk   

Department of Healthcare Management, Pharmacotherapy, and Clinical Pharmacy, Lviv National Medical University, Pekarska St 69, 21012, Lviv, Ukraine
 
 
Wiadomości Lekarskie 2024;77(1):153-159
 
KEYWORDS
TOPICS
ABSTRACT
Abstract: The given study draws on there view of materials and sources highlighting recent available research finding sand is aimed at analysing the latest advancements in the research on the function and dysfunction of mitochondria, which is recognized to be one of the crucial factors in the initiation and progression of atherosclerosis.Understanding the mechanism of mitochondrial dysfunction in cardiovascular diseases is an important challenge for the development of directly mitochondria-targeted strategies in approaching the issue of accountability for cardiovascular disorder risks. Mitochondrial dysfunction is associated with oxidative stress, calcium dyshomeostasis, defective ATP synthesis, and induction of the permeability transition pore. Therefore, therapy aimed at preventing these types of damages is beneficial and can be used in the treatment of atherosclerosis.The development of drugs with enhanced antioxidant activity, specifically targeting mitochondria, is crucial for approaches in the treatment of cardiovascular diseases wherein oxidative stress is highly implicated.
eISSN:2719-342X
ISSN:0043-5147
Journals System - logo
Scroll to top